Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Platforms, advances, and technical challenges in virus-like particles-based vaccines
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
Bowen Lu, Jing Ming Lim, Boyue Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 30
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines
Caryn Myn Li Lim, Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 12
Advanced nanoscale delivery systems for mRNA-based vaccines
Maha W. Mobasher, Rais A. Ansari, Ana M. Castejón, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 3, pp. 130558-130558
Closed Access | Times Cited: 7
Establishment of the REMBAC-cassette, a rapid, efficient and manifold BacMam tool for recombinant protein expression
Manuel Reithofer, Sophie Huber, Reingard Grabherr
Journal of Biotechnology (2025) Vol. 398, pp. 183-192
Open Access
Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
Ahmed Ali, Rasha A.M. Azouz, Nahla A. Hussein, et al.
BMC Biotechnology (2025) Vol. 25, Iss. 1
Open Access
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist—Synthesis, Characterization, and In Vivo Activity
Thomas R. Fuerst, Alexander Marin, Sarah Jeong, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 1, pp. 34-34
Open Access
Revolutionizing Nanovaccines: A New Era of Immunization
Mohammed A. Saleh, Ahmed El-Moghazy, Adel Helmy Elgohary, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 126-126
Open Access
Virus‐like particles as powerful vaccination strategy against human viruses
Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Mohammed A. Almalki, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 17
Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems
Zhe Wang, Xinpei Wang, Wanting Xu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2623-2623
Open Access | Times Cited: 14
Heparin-affinity chromatography is a generic purification platform for chimeric gag VLPs displaying different viral surface antigens
Alexander M Zollner, Leticia Guzman Ruiz, Viktoria Mayer, et al.
Separation and Purification Technology (2024) Vol. 340, pp. 126673-126673
Open Access | Times Cited: 4
Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System
Vacis Tatarūnas, Ieva Čiapienė, Agnė Giedraitienė
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 292-292
Open Access | Times Cited: 3
The Applications of Artificial Intelligence (AI)-Driven Tools in Virus-Like Particles (VLPs) Research
Bugude Laxmi, P. Uma Maheswari Devi, Naveen Thanjavur, et al.
Current Microbiology (2024) Vol. 81, Iss. 8
Closed Access | Times Cited: 3
Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases
Ilona Nowak, Marcel Madej, Julia Secemska, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1931-1931
Open Access | Times Cited: 8
Modularized viromimetic polymer nanoparticle vaccines (VPNVaxs) to elicit durable and effective humoral immune responses
Zichao Huang, Xinyu Zhuang, Liping Liu, et al.
National Science Review (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 8
Nucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming
Hannia V. Balcorta, Veronica Guerrero, Deepali Bisht, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 5020-5036
Closed Access | Times Cited: 2
New insights for the development of efficient DNA vaccines
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems
Zhe Wang, Xinpei Wang, Wanting Xu, et al.
(2023)
Open Access | Times Cited: 7
Investigation of the Electrokinetic Properties of HIV-Based Virus-Like Particles
Tobias Wolf, Christoph Grau, Jamila Franca Rosengarten, et al.
Langmuir (2024) Vol. 40, Iss. 9, pp. 4762-4771
Closed Access | Times Cited: 1
Tailored Viral-like Particles as Drivers of Medical Breakthroughs
Rafael Travassos, Sofia A. Martins, Ana Fernandes, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6699-6699
Open Access | Times Cited: 1
Gold Nanoparticle Virus-like Particles Presenting SARS-CoV-2 Spike Protein: Synthesis, Biophysical Properties and Immunogenicity in BALB/c Mice
Vivian A. Salazar, Joan Comenge, Rosa Suárez-López, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 829-829
Open Access | Times Cited: 1
Virus-like Particles Produced in Plants: A Promising Platform for Recombinant Vaccine Development
Eugenia S. Mardanova, Egor A. Vasyagin, Nikolai V. Ravin
Plants (2024) Vol. 13, Iss. 24, pp. 3564-3564
Open Access | Times Cited: 1
Novel Therapeutic Approaches for the Management of Hepatitis Infections
Aswin Damodaran, Subin Mary Zachariah, Sreeja C. Nair
Therapeutic Delivery (2024) Vol. 15, Iss. 3, pp. 211-232
Closed Access | Times Cited: 1
Advances in virus-like particle-based SARS-CoV-2 vaccines
Xiaoting Hao, Feifei Yuan, Xuan Yao
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection
Kaiwen Yang, Youqin Zeng, Xinyu Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects
Christy A. George, Srishti U. Sahu, Lorena de Oñate, et al.
The CRISPR Journal (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top